Advice to Young Oncologists

Hematology oncology experts discuss recent developments in CAR T-cell therapies as well as bispecific therapies for the treatment of patients with R/R MM.

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

Tips from experts on how to think about and manage adverse events in patients with diffuse large B-cell lymphoma.

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.

Davide Rossi, MD, spoke about the impact of the MZL workshop and his hopes for the future of treatment and medicine in MZL.

As MZL is such a rare subtype of lymphoma, it can be hard to find or begin trials geared specifically toward this population.